Clinical outcome after endoscopic submucosal dissection for early gastric cancer of absolute and expanded indication; Retrospective Single Center S...

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter H.S. Eun
Citation Annals of Oncology (2016) 27 (2): 1-85. 10.1093/annonc/mdw199
Authors H.S. Eun1, J.K. Sung2, H.Y. Jeong3, H.S. Moon4
  • 1Chungnam National Hospital, Daejeon, Republic of Korea, /
  • 2Departments of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Republic of Korea, /
  • 3Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Republic of Korea, /
  • 4Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Republic of Korea, /

Abstract

Recently, endoscopic submucosal dissection (ESD) has been the main procedure of treatment of early gastric cancer (EGC), and that area is gradually expanding, but there is still a controversial question. Thus, this study aims to evaluate the safety of ESD in submucosal (SM) invasion or undifferentiated EGC and find factors related to local recurrence after ESD.